Organogenesis Stock: Finding A Spot In My Bio Boom Portfolio
seekingalpha.com
finance
2022-10-18 08:53:17

KanawatTH The market-wide sell-off has allowed me to establish positions in wish list tickers and add to some of my favorite positions. In addition, the indiscriminate selling pressure has uncovered countless investment opportunities in the small and mid-cap healthcare arena. Organogenesis (NASDAQ:ORGO) is a small-cap regenerative medicines company that is trading a significant discount after dropping ~72% over the past twelve months despite being a profitable company with respectable upside potential.
